Pharmaceutical agents for preventing the development of tolerance during the treatment with benzodiazepine-receptor-binding active ingredients

US5614509A · kind A · utility

Assignee

• SCHERING CORPORATION · US

Inventors

• Lechoslaw Turski · Berlin, DE
• Karin G. Steppuhn · Berlin, DE
• Herbert Schneider · Berlin, DE
• David N. Stephens · Berlin, DE

Key dates

• Filing date: Mar 2, 1995
• Grant date: Mar 25, 1997
• Expiry date: Mar 2, 2015

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The use of NMDA receptor antagonists or their physiologically compatible salts for preventing the development of tolerance during the long-term treatment with benzodiazepine-receptor-binding active ingredients as well as the combination of new pharmaceutical agents with benzodiazepine-receptor-binding active ingredients is described.